GlobalData on MSN2d
Telix’s prostate cancer imaging agent approved in Brazil
Brazilian Health Regulatory Agency (ANVISA) has granted approval for Telix Pharmaceuticals’ Illuccix, a prostate cancer ...
Stockhead on MSN2d
Health Check: Fantastico! Telix wins Brazilian assent for prostate cancer imaging agent
Brazil's health regulators have approved Telix Pharmaceuticals' nuclear imaging agent for prostate cancer, Illucix. ... Read ...
Capital Brief3d
Telix's prostate cancer treatment Illuccix approved in Brazil
Melbourne-based biotech Telix Pharmaceuticals has announced that its prostate cancer diagnostic agent Illuccix has been ...
Macau Business2d
Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America
The marketing authorization is granted to Telix’s partner R2PHARMA, Brazil’s leading cold kit manufacturer, nuclear pharmacy ...
Seeking Alpha28d
Telix Pharmaceuticals Limited (TLPPF) FY 2024 Results Earnings Call Transcript
Telix finished the year with a very respectable ... market and also our manufacturing joint venture with R2 Pharma in Brazil. And so what you can really see is that we’re committed to that ...
Business Insider3d
Wilsons Remains a Buy on Telix Pharmaceuticals Ltd. (TLPPF)
In a report released today, Shane Storey from Wilsons maintained a Buy rating on Telix Pharmaceuticals Ltd. (TLPPF – Research Report), with a price target of A$35.00. The company’s shares ...
Mena FN8d
Telix Adds Lead-212 Isotope Production Capability
(MENAFN- GlobeNewsWire - Nasdaq) MELBOURNE, Australia and INDIANAPOLIS, March 13, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces ...
Morningstar3d
Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America
MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the Brazilian ...